Roxanne Nelson RN, BSN January 05, 2022 The antidepressant bupropion failed to improve sexual dysfunction in female cancer survivors, according to new findings. Using the Female Sexual Function Index (FSFI) as a measurement tool, investigators found that desire scores were not significantly different for participants who received bupropion versus a placebo over the 9-week study period. “Sexual health...